Advertisement
U.S. markets open in 3 hours 59 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed Price. Currency in USD
51.59-0.75 (-1.43%)
At close: 04:00PM EDT
51.94 +0.35 (+0.68%)
Pre-Market: 05:13AM EDT
  • Dividend

    BMY announced a cash dividend of 0.60 with an ex-date of Apr. 4, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close52.34
Open52.58
Bid0.00 x 1200
Ask0.00 x 1200
Day's Range51.53 - 52.70
52 Week Range47.58 - 71.07
Volume19,439,344
Avg. Volume17,096,811
Market Cap104.325B
Beta (5Y Monthly)0.37
PE Ratio (TTM)13.37
EPS (TTM)3.86
Earnings DateApr 25, 2024
Forward Dividend & Yield2.40 (4.65%)
Ex-Dividend DateApr 04, 2024
1y Target Est50.18
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-13% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BMY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bristol-Myers Squibb Company
    Technical Assessment: Neutral in the Intermediate-TermIn the past week, we have had little economic and EPS data, but we have had some interesting price action across the stock, bond, commodity, and currency markets. That caught us, as well as others, by surprise. But it is a big world out there and we try to avoid missing the forest for the trees!
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • The Wall Street Journal

    James D. Robinson III, Who Tried to Diversify American Express Far Beyond Cards, Dies at 88

    James D. Robinson III, who transformed American Express into a financial-services supermarket but left the company in 1993 after a high-profile clash with its directors, died Monday at the St. Francis Hospital in Roslyn, N.Y. The courtly son of a prominent banking family in Atlanta, Robinson was regularly in the headlines as he assembled and then began dismantling a financial conglomerate in the 1980s and early 1990s. Both of them were involved in the 1988 takeover battle for control of the cookie and cracker giant RJR Nabisco, which inspired the book and movie “Barbarians at the Gate.”

  • Zacks

    Bristol Myers' (BMY) Abecma Gets ODAC Votes for Label Expansion

    Bristol Myers' (BMY) Abecma gets eight out of 11 votes from the FDA's ODAC for patients with triple-class exposed relapsed or refractory multiple myeloma in earlier lines of therapy.

  • Business Wire

    Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio

    PRINCETON, N.J., March 18, 2024--Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. ("Karuna"). With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb ("BMS").